Skip to content

Ventria Bioscience

  • Medicines
    • Infectious Disease
    • Inflammatory Disease
  • Technology
    • ExpressTec
    • Evidence
    • In Context
    • Partnerships
    • BioShare
  • Our Purpose
  • About
    • People
    • News & Press
    • Contact Us
    • Careers
Medicines Our Science
  • Ventria Difference
  • Medicines
    • Infectious Disease
      • VEN BETA
    • Inflammatory Disease
      • VEN120
  • Technology
    • ExpressTec
    • Evidence
    • Partnerships
    • BioShare
  • About Us
    • Careers
    • Contact Us
    • People
    • News & Press
  • Newsletter Signup
  • Site map
  • Privacy Policy
  • FCOI Policy

Home / Partners / University of Minnesota

University of Minnesota

Ventria Bioscience has previously collaborated with Jason Baker, MD, MS at the University of Minnesota/Hennepin County Medical Center on a pilot clinical trial, Recombinant Human Lactoferrin to Reduce Immune Activation and Coagulation Among HIV Positive Patients: A pilot study.

Categories

  • In Context
  • News – Press

Recent

  • Ventria Bioscience wins exclusion order against infringing and mislabled products from Wuhan Healthgen
  • Ventria Bioscience has doubled biomanufacturing capacity for cell culture products
  • CuraVive, the Next Generation Plant-Based Food Ingredients
  • Ventria Bioscience Inc. Scores Key Victory in Fight Against Infringing Chinese Recombinant Albumin
  • Secretory IgA: potential new weapon against respiratory transmission of SARS-CoV-2?

Subscribe today to our In Context blog feed, where you will be emailed the latest product news, research, and industry insights.

© Ventria Bioscience Inc. All Rights Reserved 2023

Sitemap | Terms & Privacy |